Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OCX Gross Margin

The Gross Margin of OncoCyte Corp (OCX) is 39.34%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

OCX Gross Margin - Historical Value
Date Value
2024-12-31 39.34%
2023-12-31 27.48%
2022-12-31 -2.08%
2021-12-31 64.55%
2020-12-31 -52.46%
OCX Gross Margin - Peers Comparison